Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 61 (HNRNPA1P61)

Target
HNRNPA1P61
Molecular classification
Other (pseudogene)
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 61 (HNRNPA1P61) is classified as a *processed pseudogene* related to the HNRNPA1 gene, which encodes an RNA-binding protein involved in various aspects of mRNA processing, including splicing and regulation of mRNA transport[1][7]. Pseudogenes like HNRNPA1P61 do not produce functional proteins due to mutations such as early stop codons or frameshifts. Some pseudogenes may have regulatory roles, such as acting as decoys for regulatory RNAs or influencing gene expression by other noncoding mechanisms, but there is no published evidence that HNRNPA1P61 is transcribed or has such a role[7]. Therefore, HNRNPA1P61 is not a canonical drug target, nor is there evidence for involvement in human disease. If you require information on the functional gene *HNRNPA1* (not the pseudogene), which is a member of the heterogeneous nuclear ribonucleoproteins involved in RNA processing and associated with diverse biological processes and disease, please specify.

Other names
HNRNPA1P61Heterogeneous nuclear ribonucleoprotein A1 pseudogene 61
02

Mechanism of action

None (no demonstrated mechanism—pseudogenes are non-coding)

03

Biological functions

Potential roles as a noncoding RNA if transcribed, but not as an active protein.General pseudogene functions can include acting as regulatory RNAs, sometimes serving as competitive endogenous RNAs (ceRNAs) for microRNAs, but specific functions for HNRNPA1P61 are not documented.
04

Disease associations

Other (Pseudogenes as a class may participate in disease-related regulatory networks, but there is no direct evidence tying HNRNPA1P61 to a specific disease)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 61 (HNRNPA1P61).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 61 (HNRNPA1P61).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call